Sanofi
- Country
- 🇫🇷France
- Ownership
- Public
- Employees
- 87.9K
- Market Cap
- $141.3B
- Website
- http://www.sanofi.com
- Introduction
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Phase 1/1b Dose Escalation Study Evaluating BSI-201 as a Single Agent and in Combination With Irinotecan in Subjects With Advanced Solid Tumors
- First Posted Date
- 2006-03-03
- Last Posted Date
- 2012-08-02
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 59
- Registration Number
- NCT00298675
- Locations
- 🇺🇸
Research Site, San Antonio, Texas, United States
Insulin Glulisine in Type 1 Diabetes Mellitus
- Conditions
- Type 1 Diabetes Mellitus
- First Posted Date
- 2006-02-28
- Last Posted Date
- 2009-12-07
- Lead Sponsor
- Sanofi
- Registration Number
- NCT00297583
Ambien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro)
- Conditions
- Insomnia
- First Posted Date
- 2006-02-27
- Last Posted Date
- 2007-10-12
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 372
- Registration Number
- NCT00296790
- Locations
- 🇺🇸
Sanofi-Aventis, Bridgewater, New Jersey, United States
PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome
- Conditions
- Metabolic Syndrome x
- First Posted Date
- 2006-02-27
- Last Posted Date
- 2011-01-11
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 216
- Registration Number
- NCT00296803
- Locations
- 🇺🇸
Sanofi-Aventis, Bridgewater, New Jersey, United States
TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary
- Conditions
- Ovarian Cancer
- Interventions
- First Posted Date
- 2006-02-27
- Last Posted Date
- 2012-08-23
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 132
- Registration Number
- NCT00296816
- Locations
- 🇺🇸
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States
ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation
- Conditions
- Myocardial IschemiaHypertension
- First Posted Date
- 2006-02-24
- Last Posted Date
- 2009-10-15
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 440
- Registration Number
- NCT00296218
- Locations
- 🇬🇧
Sanofi-Aventis, Guildford, United Kingdom
Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro
- Conditions
- Insomnia
- First Posted Date
- 2006-02-24
- Last Posted Date
- 2008-07-28
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 372
- Registration Number
- NCT00296179
Drotaverine in Dysmenorrhoea Treatment
- Conditions
- Dysmenorrhea
- Interventions
- First Posted Date
- 2006-02-16
- Last Posted Date
- 2017-08-08
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 480
- Registration Number
- NCT00292747
- Locations
- 🇭🇺
Sanofi-Aventis, Budapest, Hungary
STILDEP: Zolpidem in Depressive and Dysthimic Patients
- Conditions
- Sleep Initiation and Maintenance DisordersDepression
- First Posted Date
- 2006-02-16
- Last Posted Date
- 2007-12-06
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 120
- Registration Number
- NCT00292734
- Locations
- 🇭🇺
Sanofi-Aventis, Budapest, Hungary
Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer
- Conditions
- Stomach Neoplasm
- First Posted Date
- 2006-02-13
- Last Posted Date
- 2009-04-29
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 610
- Registration Number
- NCT00290966